GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Cilnidipine + Telmisartan + Chlorthalidone Tablets (10mg+40mg+12.5mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated tablet contains:
Cilnidipine IP…………………………………………10mg
Telmisartan IP………………………………………40mg
Chlorthalidone IP…………………………………..6.25mg
Excipients………………………………………………q.s
Colour: Iron Oxide Yellow
B) Cilnidipine + Telmisartan + Chlorthalidone Tablets (10mg+40mg+12.5mg)
Each film coated tablet contains:
Cilnidipine IP…………………………………………10mg
Telmisartan IP………………………………………40mg
Chlorthalidone IP…………………………………..12.5mg
Excipients………………………………………………q.s
Colour: Sunset Yellow FCF
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
Moisture sensitive tablets- do not remove from strip until immediately before administration.
WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician
Cilnidipine +Telmisartan + Chlorthalidone Tablets (10mg+40mg+6.25mg) Technical Specification:
| Product Name: | Cilnidipine + Telmisartan + Chlorthalidone Tablets |
| Brand Name: | Generic |
| Strength: | (10mg+40mg+6.25mg), (10mg+40mg+12.5mg) |
| Dosage Form: | Tablets (Film coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 Blister strips of 10 Tablets Each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antihypertensive |
| Indication: | Telmisartan + Cilnidipine + Metoprolol Succinate belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke. |
| Storage: | Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Cilnidipine + Telmisartan + Chlorthalidone Tablets (10mg+40mg+6.25mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Cilnidipine + Telmisartan + Chlorthalidone Tablets (10mg+40mg+6.25mg)
Each film coated tablet contains:
Cilnidipine IP…………………………………………10mg
Telmisartan IP………………………………………40mg
Chlorthalidone IP…………………………………..6.25mg
Excipients………………………………………………q.s
Colour: Iron Oxide Yellow
THERAPEUTIC INDICATIONS:
Telmisartan + Cilnidipine + Metoprolol Succinate belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
Moisture sensitive tablets- do not remove from strip until immediately before administration.
WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
